Treatment for relapsed or refractory chronic lymphocytic leukaemia: an ongoing challenge

被引：1
|
作者：
Strati, Paolo [1 ]
机构：
[1] Univ Texas Houston, MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
来源：
LANCET HAEMATOLOGY | 2017年 / 4卷 / 03期
关键词：
IDELALISIB; FLUDARABINE; RITUXIMAB;
D O I：
10.1016/S2352-3026(17)30020-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E97 / E98
页数：2
相关论文
共 50 条
  • [41] Lenalidomide is an active agent in relapsed and treatment-refractory chronic lymphocytic leukemia
    Ferrajoh, A.
    O'Brien, S.
    Faderl, S.
    Wierda, W.
    Lee, B.
    Reuben, J.
    Schlette, E.
    Estrov, Z.
    Keating, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 130 - 130
  • [42] Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study
    Iannitto, Emilio
    Morabito, Fortunato
    Mancuso, Salvatrice
    Gentile, Massimo
    Montanini, Antonella
    Augello, Accursio
    Bongarzoni, Velia
    D'Arco, Alfonso
    Di Renzo, Nicola
    Fazzi, Rita
    Franco, Giovanni
    Marasca, Roberto
    Mule, Antonino
    Musso, Maurizio
    Musto, Pellegrino
    Pennese, Elsa
    Piccin, Andrea
    Rota-Scalabrini, Delia
    Visani, Giuseppe
    Rigacci, Luigi
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (03) : 351 - 357
  • [43] Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs
    Smolewski, Piotr
    Robak, Tadeusz
    ACTA HAEMATOLOGICA, 2021, 144 (04) : 365 - 379
  • [44] Ibrutinib-Based Therapy in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia
    Kuvshinov, Alexey
    Voloshin, Sergei
    Martynkevich, Irina
    Martynenko, Ludmila
    Garifullin, Andrei
    Kleina, Elizaveta
    Shuvaev, Vasily
    BLOOD, 2016, 128 (22)
  • [45] Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
    Spacek, Martin
    Smolej, Lukas
    Simkovic, Martin
    Nekvindova, Lucie
    Kristkova, Zlatuse
    Brychtova, Yvona
    Panovska, Anna
    Maslejova, Stanislava
    Bezdekova, Lucie
    Ecsiova, Dominika
    Vodarek, Pavel
    Zuchnicka, Jana
    Mihalyova, Jana
    Urbanova, Renata
    Turcsanyi, Peter
    Lysak, Daniel
    Novak, Jan
    Brejcha, Martin
    Likarova, Tereza
    Vodicka, Prokop
    Baranova, Jana
    Trneny, Marek
    Doubek, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (01) : 40 - 47
  • [46] Refractory CIDP with chronic lymphocytic leukaemia responding to chemoimmunotherapy
    Lewis, Dana
    Osman, Chinar
    Allen, David
    Pinto, Ashwin Arnold
    Duncombe, Andrew
    Katifi, Haider A.
    PRACTICAL NEUROLOGY, 2021, 21 (02) : 143 - 146
  • [47] A case of refractory chronic lymphocytic leukaemia with an unusual course
    Umit, Elif G.
    Baysal, Mehmet
    Ozdover, Ali Caner
    Kirkizlar, Onur
    Demir, Ahmet Muzaffer
    NATIONAL MEDICAL JOURNAL OF INDIA, 2019, 32 (06): : 347 - +
  • [48] Fludarabine monophosphate as salvage for refractory chronic lymphocytic leukaemia
    Pillay, GS
    Wood, L
    Jacobs, P
    SOUTH AFRICAN MEDICAL JOURNAL, 1996, 86 (08): : 949 - 951
  • [49] Indirect Treatment Comparison of Venetoclax plus Rituximab with B-cell Receptor Inhibitors in Patients with Relapsed/Refractory Chronic Lymphocytic Leukaemia
    Mato, A.
    Follows, G.
    Sail, K.
    Diakite, I.
    Nicoloso, D.
    Dietz, B.
    Maher, J.
    Alexiou, D.
    Chirikov, V.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 91 - 92
  • [50] Embracing chimeric antigen receptors for relapsed chronic lymphocytic leukaemia
    Kamdar, Manali
    LANCET, 2023, 402 (10402): : 590 - 592
12345